Hereditary Angioedema



Date: Fri, March 1st
Time: 9 AM PST / 11 AM CST / 12 PM EST
Duration: 40 min

Register Now!


  • Disease burden and quality of life in HAE: 10 min
  • Long-term prophylaxis therapies for HAE: 10 min
  • Discussion and Q&A: 20 min


Upon completion of this activity, participants should be able to

  • Recognize that disease burden is substantial and anxiety/depression is common in hereditary angioedema.
  • Inquire about quality of life (QoL) at every patient’s visit and know the tools to evaluate the severity of the issue.
  • Assess the role of long-term prophylactic therapies in improving QoL and achieving normalization of life.


John Anderson, MD

Dr. John Anderson is an allergy and immunology specialist at AllerVie Health in Alabama. He is a nationally recognized physician expert in the field of hereditary angioedema. He has published extensively on various topics of the disease.

Njeri Maina, MD PhD

Dr. Njeri Maina is an allergy and immunology specialist at Atlanta Allergy & Asthma in Georgia. Dr. Maina’s research interest includes the management of hereditary angioedema. Her work on the subject was published in peer-reviewed journals.

Amber Nelson, NP

Amber Nelson is a nurse practitioner at AllerVie Health in Alabama. She is experienced in caring for patients with hereditary angioedema. She advocates for her patients. She guides them through the treatment course. She helps them to achieve the best outcomes.


Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

John Anderson, MD

  • Grant/Research Support: : CSL Behring, Takeda, Pharming, BioCryst, Kalvista, Pharvaris, Biomarin, Astria
  • Consultant/Advisory Board: CSL Behring, Takeda, Pharming, BioCryst, Kalvista, Pharvaris, Ionis, Astria, Cycle Pharma
  • Speakers Bureau/Honoraria for non-CME: CSL Behring, Takeda, Pharming. BioCryst

Njeri Maina, MD

  • Nothing to Disclose

Amber Nelson, NP

  • Nothing to Disclose


The PIM planners and others have nothing to disclose. The P2P Syncro planners and others have nothing to disclose.

CME Credit

This program is provided by P2P Syncro and Postgraduate Institute for Medicine. It is supported by an independent educational grant from Takeda.

The following CME credits are offered at no cost.

  • Physicians: max of 1.0 AMA PRA Category 1 Credit(s)™
  • Nurses: 1.0 Contact Hour
  • Physician Assistants: 1.0 CE Credit
  • Pharmacists: 1.0 Contact Hour

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and P2P Syncro. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education: The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.

Pharmacy Continuing Education: Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008162-9999-24-003-L01-P. Type of Activity: Knowledge.

Physician Assistant Continuing Education: Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Information on how to receive CME credit will be provided to registered providers by email on 3/1/2024


Please contact P2P Syncro at for questions about this educational activity (e.g., access to webinar, receiving CME credit)